Children ages 2–17 with mild to moderate eczema (atopic dermatitis) are needed for a study investigating whether crisaborole (Eucrisa) reduces topical steroid usage. Participation involves surveys, steroid usage diaries, skin exams, and photographs. Participants will be asked to make three study visits (by video); compensation is up to $400.
Principal investigator: Anna Grossberg, MD, Johns Hopkins Department of Dermatology
IRB protocol no.: IRB00178631
For more information, contact the Cutaneous Translational Research Program: email@example.com